{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:57:18Z","timestamp":1790060238084,"version":"4.0.1"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7,1]]},"abstract":"<jats:p>OBJECTIVE. The goal was to study the incidence of kernicterus, developmental delay, autism, cerebral palsy, and hearing loss in infants with peak total serum bilirubin levels of \u2265325 \u03bcmol\/L (\u226519 mg\/dL), compared with infants with less-severe or no hyperbilirubinemia, in a population of healthy term and late preterm infants.<\/jats:p><jats:p>METHODS. Prospectively gathered, standardized, maternal and neonatal data for infants at \u226535 weeks of gestation who were born between January 1, 1994, and December 31, 2000, were extracted from the Nova Scotia Atlee Perinatal Database. Infants with Rh factor isoimmunization, significant congenital or chromosomal abnormalities, or severe peripartum asphyxia were excluded. Comparisons were made on the basis of peak total serum bilirubin levels. Diagnoses were obtained through data linkage with the Medical Services Insurance Database for office visits and the Canadian Institute for Health Information Database for hospital admissions. The registration file provided information allowing calculation of follow-up times, which were determined for each separate outcome. Follow-up periods ranged from 2 to 9 years, with the end point being the first time the diagnostic code was encountered in either database. Cox proportional-hazards regression analyses were used to examine the relationships between outcomes and total serum bilirubin levels.<\/jats:p><jats:p>RESULTS. Of 61238 infants included in the study cohort, 4010 (6.7%) did not have linkage data, which left 56019 infants for analysis. There were no cases of kernicterus and no significant differences in rates of cerebral palsy, deafness, developmental delay, or visual abnormalities between the groups. There were suggestions of associations with attention-deficit disorder in the severe hyperbilirubinemia group and with autism in the combined moderate and severe hyperbilirubinemia group.<\/jats:p><jats:p>CONCLUSIONS. There was no increase in adverse effects reported previously to be associated with bilirubin toxicity. Associations with developmental delay, attention-deficit disorder, and autism were observed.<\/jats:p>","DOI":"10.1542\/peds.2007-0967","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T13:29:15Z","timestamp":1214918955000},"page":"119-124","source":"Crossref","is-referenced-by-count":70,"title":["Outcomes in a Population of Healthy Term and Near-Term Infants With Serum Bilirubin Levels of \u2265325 \u03bcmol\/L (\u226519 mg\/dL) Who Were Born in Nova Scotia, Canada, Between 1994 and 2000"],"prefix":"10.1542","volume":"122","author":[{"given":"Krista A.","family":"Jangaard","sequence":"first","affiliation":[{"name":"Department of Neonatal-Perinatal Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshayne B.","family":"Fell","sequence":"additional","affiliation":[{"name":"Perinatal Epidemiology Research Unit, Dalhousie University, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Dodds","sequence":"additional","affiliation":[{"name":"Perinatal Epidemiology Research Unit, Dalhousie University, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Neonatal-Perinatal Medicine"},{"name":"Perinatal Epidemiology Research Unit, Dalhousie University, Halifax, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2008,7,1]]},"reference":[{"key":"2021120905551698800_R1","unstructured":"Holtrop PC, Maisels MJ. Hyperbilirubinemia in Intensive Care of the Fetus and Neonate. Philadelphia, PA: Mosby-Year Book; 1996:888\u2013898"},{"key":"2021120905551698800_R2","doi-asserted-by":"crossref","unstructured":"Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics.1991;87(6):797\u2013805","DOI":"10.1542\/peds.87.6.797"},{"key":"2021120905551698800_R3","doi-asserted-by":"crossref","unstructured":"Connolly AM, Volpe JJ. Clinical features of bilirubin encephalopathy. Clin Perinatol.1990;17(2):371\u2013379","DOI":"10.1016\/S0095-5108(18)30573-6"},{"key":"2021120905551698800_R4","unstructured":"Scheidt PC, Bryla DA, Nelson KB, Hirtz DG, Hoffman HJ. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics.1990;85(4):455\u2013463"},{"key":"2021120905551698800_R5","doi-asserted-by":"crossref","unstructured":"Soorani-Lunsing I, Woltil HA, Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?Pediatr Res.2001;50(6):701\u2013705","DOI":"10.1203\/00006450-200112000-00012"},{"key":"2021120905551698800_R6","doi-asserted-by":"crossref","unstructured":"Grimmer I, Berger-Jones K, Bu\u0308hrer C, Brandl U, Obladen M. Late neurological sequelae of non-hemolytic hyperbilirubinemia of healthy term neonates. Acta Paediatr.1999;88(6):661\u2013663","DOI":"10.1111\/j.1651-2227.1999.tb00018.x"},{"key":"2021120905551698800_R7","unstructured":"Deorari AK, Singh M, Ahuja GK, et al. One year outcome of babies with severe neonatal hyperbilirubinemia and reversible abnormality in brainstem auditory evoked responses. Indian Pediatr.1994;31(8):915\u2013921"},{"key":"2021120905551698800_R8","doi-asserted-by":"crossref","unstructured":"Ozmert E, Erdem G, Topcu M, et al. Long-term follow-up of indirect hyperbilirubinemia in full-term Turkish infants. Acta Paediatr.1996;85(12):1440\u20131444","DOI":"10.1111\/j.1651-2227.1996.tb13949.x"},{"key":"2021120905551698800_R9","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics.1994;94(4):558\u2013562","DOI":"10.1542\/peds.94.4.558"},{"key":"2021120905551698800_R10","unstructured":"Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert. Oak Brook Terrace, IL: Joint Commission on Accreditation of Healthcare Organizations, Issue 18, April 1, 2001"},{"key":"2021120905551698800_R11","unstructured":"Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics.1999;104(suppl 3):736"},{"key":"2021120905551698800_R12","doi-asserted-by":"crossref","unstructured":"Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr.2000;89(10):1213\u20131217","DOI":"10.1111\/j.1651-2227.2000.tb00738.x"},{"key":"2021120905551698800_R13","unstructured":"Centers for Disease Control and Prevention. Kernicterus in full-term infants: United States 1994\u20131998. MMWR Morb Mortal Wkly Rep.2001;50(23):491\u2013494"},{"key":"2021120905551698800_R14","doi-asserted-by":"crossref","unstructured":"Maisels MJ, Newman TB. Kernicterus in otherwise healthy breast-fed term newborns. Pediatrics.1995;96(4):730\u2013733","DOI":"10.1542\/peds.96.4.730"},{"key":"2021120905551698800_R15","doi-asserted-by":"crossref","unstructured":"Hansen TW. Kernicterus in term and near-term infants: the specter walks again. Acta Paediatr.2000;89(10):1155\u20131157","DOI":"10.1080\/080352500750027484"},{"key":"2021120905551698800_R16","doi-asserted-by":"crossref","unstructured":"Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics.2001;107(5):1075\u20131080","DOI":"10.1542\/peds.107.5.1075"},{"key":"2021120905551698800_R17","doi-asserted-by":"crossref","unstructured":"Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics.1993;92(5):651\u2013657","DOI":"10.1542\/peds.92.5.651"},{"key":"2021120905551698800_R18","doi-asserted-by":"crossref","unstructured":"Newman TB, Liljestrand P, Jeremy RJ, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med.2006;354(18):1889\u20131900","DOI":"10.1056\/NEJMoa054244"},{"key":"2021120905551698800_R19","doi-asserted-by":"crossref","unstructured":"Grether JK, Cummins SK, Nelson KB. The California Cerebral Palsy Project. Paediatr Perinat Epidemiol.1992;6(3):339\u2013351","DOI":"10.1111\/j.1365-3016.1992.tb00774.x"},{"key":"2021120905551698800_R20","doi-asserted-by":"crossref","unstructured":"Cone-Wesson B, Vohr BR, Sininger YS, et al. Identification of neonatal hearing impairment: infants with hearing loss. Ear Hear.2000;21(5):488\u2013507","DOI":"10.1097\/00003446-200010000-00012"},{"key":"2021120905551698800_R21","doi-asserted-by":"crossref","unstructured":"Boo NY, Oakes M, Lye MS, Said H. Risk factors associated with hearing loss in term neonates with hyperbilirubinemia. J Trop Pediatr.1994;40(4):194\u2013197","DOI":"10.1093\/tropej\/40.4.194"},{"key":"2021120905551698800_R22","doi-asserted-by":"crossref","unstructured":"Wong V, Chen WX, Wong KY. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol.2006;21(4):309\u2013315","DOI":"10.1177\/08830738060210040301"},{"key":"2021120905551698800_R23","doi-asserted-by":"crossref","unstructured":"Juul-Dam N, Townsend J, Courchensne E. Prenatal, perinatal and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics.2001;107(4). Available at: www.pediatrics.org\/cgi\/content\/full\/107\/4\/e63","DOI":"10.1542\/peds.107.4.e63"},{"key":"2021120905551698800_R24","doi-asserted-by":"crossref","unstructured":"Croen LA, Yoshida CK, Odouli R, Newman TB. Neonatal hyperbilirubinemia and risk of autism spectrum disorders. Pediatrics.2005;115(2). Available at: www.pediatrics.org\/cgi\/content\/full\/115\/2\/e135","DOI":"10.1542\/peds.2004-1870"},{"key":"2021120905551698800_R25","doi-asserted-by":"crossref","unstructured":"Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ.2006;175(6):587\u2013590","DOI":"10.1503\/cmaj.060328"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/1\/119\/1068567\/zpe00708000119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/122\/1\/119\/1068567\/zpe00708000119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T01:36:22Z","timestamp":1684460182000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/122\/1\/119\/72972\/Outcomes-in-a-Population-of-Healthy-Term-and-Near"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,7,1]]},"published-print":{"date-parts":[[2008,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2007-0967","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,1]]}}}